TürkiyeResearch and clinical trials
Guillain-Barré after COVID-19 in Istanbul: the type affecting the nerve sheath was more common
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
A multicenter study in Istanbul compared patients with Guillain-Barré syndrome. The study compared 22 people who fell ill after COVID-19 with 69 patients from before the pandemic. In the post-COVID-19 group, the type affecting the nerve sheath was more common. The severity of the illness and the treatments given were similar in the two groups.
What does it mean for patients and families?
Guillain-Barré that develops after COVID-19 does not follow a very different course from other cases. If muscle weakness increases rapidly, go to a hospital without delay.
Source
Scientific paper: Clinical and Electrodiagnostic Characteristics of COVID-19-Associated Guillain-Barré Syndrome: A Multicenter Study. The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques, 2026. DOI: 10.1017/cjn.2026.10659 · PubMed 42788219
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Guillain-Barré syndrome (GBS)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.